GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.
EDMONTON, Alberta, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Regenx Tech Corp. (“Regenx” or the “Company”) (CSE: RGX) (OTCQB: RGXTF) is pleased to announce the appointment of John Kiland to its Board of Directors.
EDMONTON, Alberta, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp. (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) is announcing changes in its senior leadership.
EDMONTON, Alberta, July 29, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp. (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3) announces participation in upcoming investor conferences and an update on operations.
EDMONTON, Alberta, June 18, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Corporation" or "Regenx") (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) announced that, further to its June 12, 2024 news release, the Corporation has completed the consolidation (the “Consolidation”) of its Common Shares on the basis of 2 pre-Consolidation Common Shares for 1 post-Consolidation Common Share, subject to regulatory approval, including approval of the Canadian Securities Exchange (the “CSE”). As of today, the Common Shares of the Corporation will trade on a post-Consolidation basis on the CSE.
EDMONTON, Alberta, June 12, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Corporation" or "Regenx") (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) announces the results of its Annual General and Special Meeting held today. All the resolutions proposed to the shareholders detailed in the Management Information Circular dated the 29th of April, 2024 were duly passed.
EDMONTON, Alberta, June 10, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Corporation" or "Regenx") (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) announced today the successful completion of the previously announced rights offering (the “Offering”). In connection with the closing of the Offering, Regenx issued 395,508,807 common shares of the Corporation (each a “Common Share”) at a price of $0.0075 per Common Share, raising total gross proceeds of approximately $2,966,316.